Compare LENZ & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | ONL |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 165.4M |
| IPO Year | 2021 | 2021 |
| Metric | LENZ | ONL |
|---|---|---|
| Price | $3.79 | $2.44 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.00 | N/A |
| AVG Volume (30 Days) | ★ 666.8K | 191.9K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $19,088,000.00 | ★ $147,647,000.00 |
| Revenue This Year | N/A | $1.67 |
| Revenue Next Year | $153.04 | $0.11 |
| P/E Ratio | ★ N/A | $13.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.60 | $1.92 |
| 52 Week High | $49.85 | $3.05 |
| Indicator | LENZ | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 38.66 |
| Support Level | $3.60 | $2.40 |
| Resistance Level | $6.11 | $2.59 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 23.38 | 42.86 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.